Thermo Fisher Scientific Inc. (TMO) Stock Forecast
TMO analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.54 / 5 from 28 analysts
- Price target
- $690.62 average of analyst targets
- Upside to target
- +0.1% from the latest close
- Next earnings
- October 21, 2026 EPS estimate $6.40
- 52-week range
- $438.34 – $696.49
TMO analyst ratings
28 analystsNumber of analysts at each rating.
TMO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
TMO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $6.40 | $6.33 | $6.47 | $5.79 | +10.6% | 22 |
| Current fiscal year (2026) | $25.15 | $24.98 | $25.40 | $22.87 | +10.0% | 28 |
| Next fiscal year (2027) | $27.58 | $26.49 | $29.07 | $25.15 | +9.7% | 28 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
TMO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $11.93B | $11.71B | $12.02B | +7.3% | 20 |
| Current fiscal year (2026) | $47.89B | $47.71B | $48.22B | +7.5% | 26 |
| Next fiscal year (2027) | $50.36B | $49.90B | $51.49B | +5.2% | 26 |
TMO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
TMO revenue: reported and forecast
TMO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $6.37 | $6.40 | $6.41 | $6.40 | $6.40 | +0.6% | 2 up · 1 down |
| Current fiscal year (2026) | $24.85 | $25.12 | $25.13 | $25.14 | $25.15 | +1.2% | 4 up · 0 down |
| Next fiscal year (2027) | $27.25 | $27.51 | $27.53 | $27.58 | $27.58 | +1.2% | 5 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
TMO earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; TMO beat in 12 of 12.
What analysts expect from TMO
28 analysts cover Thermo Fisher; their consensus rating is strong buy (4.54 on a 1–5 scale, where 5 is a strong buy). The average price target is $690.62, 0.1% above the latest close of $690.00. Analysts expect earnings of $25.15 per share for 2026, +10.0% from a year earlier. For 2027 the average estimate is $27.58 per share on revenue of $50.4 billion. Thermo Fisher beat the EPS estimate in 12 of the last 12 quarters.
Related: TMO income statement, TMO key metrics, TMO chart. See the TMO stock overview for the latest quote and news.
TMO forecast FAQ
What is Thermo Fisher's price target?
The average analyst price target for Thermo Fisher is $690.62, 0.1% above the latest close of $690.00.
Is Thermo Fisher a buy, hold or sell?
Of 28 analysts covering Thermo Fisher, 20 rate it a strong buy, 4 a buy, 3 a hold, 1 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Thermo Fisher's EPS forecast?
Analysts forecast $25.15 per share for 2026 (range $24.98 to $25.40); for 2027 the estimate is $27.58.
What is Thermo Fisher's revenue forecast?
The average revenue estimate for 2026 is $47.9 billion, growth of 7.5%; for 2027 it is $50.4 billion.
When does Thermo Fisher report earnings?
Thermo Fisher is expected to report results for the quarter ending September 30, 2026 on October 21, 2026 before the market opens; the EPS estimate is $6.40.
Does Thermo Fisher usually beat earnings estimates?
Thermo Fisher reported EPS at or above the analyst estimate in 12 of the last 12 quarters.